Target intelligence / Profile preview

Enamel matrix proteins (EMPs)

Target
EMPs
Molecular classification
Extracellular matrix protein, Structural protein
01

Overview

Enamel matrix proteins (EMPs) are a complex mixture of proteins secreted by ameloblasts during the early stages of tooth development. While amelogenin constitutes the majority (approximately 90%) of this matrix, the term "Other enamel matrix proteins" refers to the remaining non-amelogenin components, including ameloblastin, enamelin, tuftelin, and amelotin. These proteins play a critical role in the biomineralization of enamel and the formation of the periodontal attachment apparatus, including cementum and the periodontal ligament. In a therapeutic context, these proteins are typically administered as a porcine-derived Enamel Matrix Derivative (EMD) to promote periodontal regeneration in patients with advanced gum disease. By mimicking the natural odontogenic environment, they stimulate cell signaling pathways that lead to the recruitment and differentiation of progenitor cells necessary for restoring lost periodontal tissues.

Other names
Enamel matrix derivativeEMDAmeloblastinEnamelinTuftelinAmelotinOdontogenic ameloblast-associated protein
02

Mechanism of action

Mimicry of the biological environment during tooth development to stimulate the formation of cementum, periodontal ligament, and alveolar bone by promoting the recruitment and differentiation of mesenchymal stem cells.

03

Biological functions

BiomineralizationCell adhesionCell proliferationCell differentiationTissue regeneration
04

Disease associations

PeriodontitisGingival recessionAlveolar bone lossAmelogenesis imperfecta
05

Safety considerations

Hypersensitivity to porcine-derived proteinsPost-operative inflammationRisk of root resorption (rare)
06

Interacting drugs

Enamel matrix derivative (Emdogain)
07

Biomarkers

Probing pocket depth (PPD)Clinical attachment level (CAL)Radiographic bone fill

Beyond the preview

Go deeper on Enamel matrix proteins (EMPs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enamel matrix proteins (EMPs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call